Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Evaluation of the difference in efficacy between standard and personalized transdermal nicotine replacement therapy along with an analysis of the neurological changes associated with treatment

FY 2014-15

Summary
Although 60% of smokers would like to quit, only 10% are able to do so successfully. This study is aiming to develop a treatment strategy that would help to increase the number of smokers who can quit successfully. All participants will start off with a single daily patch. Those who are able to quit after two weeks will continue to receive the single patch treatment until the study is over. Those who are unable to quit after two weeks will receive, either, additional nicotine patches or additional patches without nicotine (placebo patches). The number of additional patches a particular person receives will depend on how much they continue to smoke between bi-weekly study visits. Participants will receive additional patches until they have stopped smoking completely or until they reach the maximum limit of four patches (84 mg nicotine). Ultimately, this study will be assessing if giving nicotine patches according to individual need helps more people to quit. The study will also assess the effect of the treatment strategy and long-term quitting over time on the brain. Three brain scans will be done to determine this, one before treatment and two after. Lastly, the study will investigate whether or not genetic information can be used to explain why some people find it more difficult to quit using nicotine patches.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331452
Name
Olanbiwonnu Temitope
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Evaluation of the difference in efficacy between standard and personalized transdermal nicotine replacement therapy along with an analysis of the neurological changes associated with treatment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Drug Abuse; Functional Magnetic Resonance Imaging; Nicotine Addiction; Nicotine Patch; Smoking Cessation; Transdermal Nicotine Replacement Therapy
Abstract
Although 60% of smokers would like to quit, only 10% are able to do so successfully. This study is aiming to develop a treatment strategy that would help to increase the number of smokers who can quit successfully. All participants will start off with a single daily patch. Those who are able to quit after two weeks will continue to receive the single patch treatment until the study is over. Those who are unable to quit after two weeks will receive, either, additional nicotine patches or additional patches without nicotine (placebo patches). The number of additional patches a particular person receives will depend on how much they continue to smoke between bi-weekly study visits. Participants will receive additional patches until they have stopped smoking completely or until they reach the maximum limit of four patches (84 mg nicotine). Ultimately, this study will be assessing if giving nicotine patches according to individual need helps more people to quit. The study will also assess the effect of the treatment strategy and long-term quitting over time on the brain. Three brain scans will be done to determine this, one before treatment and two after. Lastly, the study will investigate whether or not genetic information can be used to explain why some people find it more difficult to quit using nicotine patches.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Olanbiwonnu, Temitope
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~